InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0001628280-25-051052 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-10 2025-11-07 OGN Arjona Ferreira Juan Camilo CMO, Head of R, D F - Tax $6.71 -2,307 28.9K -7% -$15.5K
D 2025-11-10 2025-11-07 OGN Arjona Ferreira Juan Camilo CMO, Head of R, D M - OptEx $0.00 +6,446 31.2K +26% $0
D 2025-11-10 2025-11-07 OGN Arjona Ferreira Juan Camilo CMO, Head of R, D M - OptEx $0.00 -6,446 6,447 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-07 F D 2,307 $6.71 28,916.36 D — —
2 Common Common Stock 2025-11-07 M A 6,446 $0.00 31,223.36 D — —
3 Derivative Restricted Stock Units 2025-11-07 M D 6,446 $0.00 6,447 D — · 2024-11-07 to 2026-11-07 6,446 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock. (F2) These restricted stock units vest and are distributed as shares of Organon common stock in three installments: 6,446 shares on November 7 2024; 6,446 shares on November 7, 2025; and 6,447 shares on November 7, 2026.